GLP-4 RETA-CAG 10MG

RETAPRO 10MG — Reta 5MG + Cagri 5MG

RETAPRO combines two research peptides in one formulation: Retatrutide (5MG) + Cagrilintide (5MG).

Retatrutide is being investigated for its activity at GLP-1, GIP, and glucagon receptors, while cagrilintide is a long-acting amylin analogue being studied for its effects on appetite, satiety, and metabolic regulation.

This combination is intended for researchers interested in studying complementary pathways involved in:

• Appetite and satiety signaling

• Energy balance and metabolism

• Glucose and metabolic regulation

• Body-weight regulation

• Multi-pathway metabolic research

Total: 10MG

Retatrutide: 5MG

Cagrilintide: 5MG

Brand: Reform Fitness

FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION.

Not intended to diagnose, treat, cure, or prevent any disease.